Stockreport

Liminal Biosciences announces effectiveness of Registration Statement on Form F-10 and filing of Prospectus Supplement

Liminal BioSciences Inc. - Common Shares  (LMNL) 
PDF LAVAL, QC, ROCKVILLE, MD and CAMBRIDGE, United Kingdom, Nov. 18, 2019 /PRNewswire/ - Liminal BioSciences Inc. (NASDAQ: LMNL) (TSX: LMNL) ("Liminal BioSciences" or the "C [Read more]